{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:40:03Z","timestamp":1793508003110,"version":"4.5.0"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Hunan Provincial Natural Science Foundation of China","award":["2025JJ80178"],"award-info":[{"award-number":["2025JJ80178"]}]},{"name":"the Changsha Natural Science Foundation of China","award":["kq2502334"],"award-info":[{"award-number":["kq2502334"]}]},{"name":"the Hunan Provincial Health High-Level Talent Support Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"DOI":"10.1186\/s40035-026-00578-w","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:45:39Z","timestamp":1786949139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The mitophagy-inflammasome axis: a shared pathological hub in Alzheimer\u2019s and Parkinson\u2019s diseases"],"prefix":"10.1186","volume":"15","author":[{"given":"Wei","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"578_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155101","volume":"121","author":"D Cui","year":"2023","unstructured":"Cui D, Chen Y, Ye B, Guo W, Wang D, He J. Natural products for the treatment of neurodegenerative diseases. Phytomedicine (Jena). 2023;121:155101.","journal-title":"Phytomedicine (Jena)"},{"key":"578_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2021.100022","volume":"2","author":"DK Khatri","year":"2021","unstructured":"Khatri DK, Kadbhane A, Patel M, Nene S, Atmakuri S, Srivastava S, et al. Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders. Curr Res Pharmacol Drug Discov. 2021;2:100022.","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"578_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.603854","volume":"12","author":"L Cui","year":"2020","unstructured":"Cui L, Hou NN, Wu HM, Zuo X, Lian YZ, Zhang CN, et al. Prevalence of Alzheimer\u2019s disease and Parkinson\u2019s disease in China: an updated systematical analysis. Front Aging Neurosci. 2020;12:603854.","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"578_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565\u201381.","journal-title":"Nat Rev Neurol"},{"key":"578_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1542607","volume":"17","author":"ZY Tian","year":"2025","unstructured":"Tian ZY, Jiang B, Jin M, Yu XK, Chen QL, Wang JH. Alzheimer\u2019s disease and insomnia: a bibliometric study and visualization analysis. Front Aging Neurosci. 2025;17:1542607.","journal-title":"Front Aging Neurosci"},{"issue":"10423","key":"578_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. The epidemiology of Parkinson\u2019s disease. Lancet. 2024;403(10423):283\u201392.","journal-title":"Lancet"},{"issue":"1","key":"578_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12951-024-02428-1","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu X, Shen L, Wan M, Xie H, Wang Z. Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles. J Nanobiotechnology. 2024;22(1):170.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"578_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40035-024-00407-y","volume":"13","author":"W Li","year":"2024","unstructured":"Li W, Li JY. Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration. Transl Neurodegener. 2024;13(1):16.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"578_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03293-3","volume":"21","author":"L Knecht","year":"2024","unstructured":"Knecht L, Dalsb\u00f8l K, Simonsen AH, Pilchner F, Ross JA, Winge K, et al. Autoantibody profiles in Alzheimer\u2019s, Parkinson\u2019s, and dementia with Lewy bodies: altered IgG affinity and IgG\/IgM\/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patterns. J Neuroinflammation. 2024;21(1):317.","journal-title":"J Neuroinflammation"},{"key":"578_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102063","volume":"91","author":"K Yang","year":"2023","unstructured":"Yang K, Zeng L, Zeng J, Deng Y, Wang S, Xu H, et al. Research progress in the molecular mechanism of ferroptosis in Parkinson\u2019s disease and regulation by natural plant products. Ageing Res Rev. 2023;91:102063.","journal-title":"Ageing Res Rev"},{"key":"578_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154801","volume":"115","author":"P Liu","year":"2023","unstructured":"Liu P, Zhou Y, Shi J, Wang F, Yang X, Zheng X, et al. Myricetin improves pathological changes in 3\u00d7Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway. Phytomedicine. 2023;115:154801.","journal-title":"Phytomedicine"},{"issue":"4","key":"578_CR12","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1002\/alz.13658","volume":"20","author":"G Bellomo","year":"2024","unstructured":"Bellomo G, Toja A, Paolini Paoletti F, Ma Y, Farris CM, Gaetani L, et al. Investigating alpha-synuclein co-pathology in Alzheimer\u2019s disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay. Alzheimers Dement. 2024;20(4):2444\u201352.","journal-title":"Alzheimers Dement"},{"key":"578_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-cellbio-120420-015303","volume":"38","author":"K Shen","year":"2022","unstructured":"Shen K, Pender CL, Bar-Ziv R, Zhang H, Wickham K, Willey E, et al. Mitochondria as cellular and organismal signaling hubs. Annu Rev Cell Dev Biol. 2022;38:179\u2013218.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"3","key":"578_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031324","volume":"22","author":"JH Lee","year":"2021","unstructured":"Lee JH, Kim HJ, Kim JU, Yook TH, Kim KH, Lee JY, et al. A novel treatment strategy by natural products in NLRP3 inflammasome-mediated neuroinflammation in Alzheimer\u2019s and Parkinson\u2019s disease. Int J Mol Sci. 2021;22(3):1324.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"578_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12071411","volume":"12","author":"BM Pizarro-Galleguillos","year":"2023","unstructured":"Pizarro-Galleguillos BM, Kunert L, Br\u00fcggemann N, Prasuhn J. Neuroinflammation and mitochondrial dysfunction in Parkinson\u2019s disease: connecting neuroimaging with pathophysiology. Antioxidants. 2023;12(7):1411.","journal-title":"Antioxidants"},{"key":"578_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.107162","volume":"217","author":"J Wei","year":"2025","unstructured":"Wei J, Xiao T, Lyu J, Zhao Y, Zhang Y, Du X, et al. Mitophagy in Alzheimer\u2019s disease and its potential as a therapeutic target. Neurobiol Dis. 2025;217:107162.","journal-title":"Neurobiol Dis"},{"issue":"13","key":"578_CR17","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","volume":"20","author":"N Kelley","year":"2019","unstructured":"Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):3328.","journal-title":"Int J Mol Sci"},{"key":"578_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.116137","volume":"273","author":"J Li","year":"2024","unstructured":"Li J, Li M, Wang R, Lan J, Yu L, Gao J, et al. Mitophagy protects against silver nanoparticle-induced hepatotoxicity by inhibiting mitochondrial ROS and the NLRP3 inflammasome. Ecotoxicol Environ Saf. 2024;273:116137.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"6","key":"578_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41435-024-00309-z","volume":"25","author":"S Rajkhowa","year":"2024","unstructured":"Rajkhowa S, Jha S. The role of NLRP3 and NLRP12 inflammasomes in glioblastoma. Genes Immun. 2024;25(6):541\u201351.","journal-title":"Genes Immun"},{"key":"578_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2024.104007","volume":"46","author":"J Zhang","year":"2024","unstructured":"Zhang J, Chang Y, Liu S, Tuo J, Xu Z, Ying J, et al. ALA-PDT promotes IL-1\u03b2 secretion from human SZ95 sebocytes via activation of the NLRP3 inflammasome. Photodiagnosis Photodyn Ther. 2024;46:104007.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"578_CR21","doi-asserted-by":"publisher","first-page":"1007705","DOI":"10.3389\/fimmu.2022.1007705","volume":"13","author":"C Moltrasio","year":"2022","unstructured":"Moltrasio C, Romagnuolo M, Marzano AV. NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: from cryopyrin function to targeted therapies. Front Immunol. 2022;13:1007705.","journal-title":"Front Immunol"},{"key":"578_CR22","doi-asserted-by":"publisher","first-page":"1214289","DOI":"10.3389\/fimmu.2023.1214289","volume":"14","author":"T Honda","year":"2023","unstructured":"Honda T, Ku J, Anders HJ. Cell type-specific roles of NLRP3, inflammasome-dependent and -independent, in host defense, sterile necroinflammation, tissue repair, and fibrosis. Front Immunol. 2023;14:1214289.","journal-title":"Front Immunol"},{"issue":"Pt 2","key":"578_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.147874","volume":"329","author":"G Wang","year":"2025","unstructured":"Wang G, Duan J, Sun L, Pan S, Liu Q, Fu K, et al. Multi-omics integration reveals key miRNAs, immune inflammation, and signaling pathways in Alzheimer\u2019s disease: Implications for targeted therapy. Int J Biol Macromol. 2025;329(Pt 2):147874.","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"578_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04906-6","volume":"13","author":"A Li","year":"2022","unstructured":"Li A, Gao M, Liu B, Qin Y, Chen L, Liu H, et al. Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease. Cell Death Dis. 2022;13(5):444.","journal-title":"Cell Death Dis"},{"issue":"1","key":"578_CR25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41420-024-02259-x","volume":"10","author":"J Wang","year":"2024","unstructured":"Wang J, Wang D. Mitophagy in gynecological malignancies: roles, advances, and therapeutic potential. Cell Death Discov. 2024;10(1):488.","journal-title":"Cell Death Discov"},{"key":"578_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103654","volume":"83","author":"C Huang","year":"2025","unstructured":"Huang C, Liao J, Cen X, Jiao C, Chen S, Liu D, et al. TJ0113-induced mitophagy in acute liver failure detected by Raman microspectroscopy. Redox Biol. 2025;83:103654.","journal-title":"Redox Biol"},{"issue":"1","key":"578_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02277-y","volume":"24","author":"H Wang","year":"2025","unstructured":"Wang H, Sun P, Yuan X, Xu Z, Jiang X, Xiao M, et al. Autophagy in tumor immune escape and immunotherapy. Mol Cancer. 2025;24(1):85.","journal-title":"Mol Cancer"},{"issue":"10","key":"578_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cells14100745","volume":"14","author":"N ALKhemeiri","year":"2025","unstructured":"ALKhemeiri N, Eljack S, Saber-Ayad MM. Perspectives of targeting autophagy as an adjuvant to anti-PD-1\/PD-L1 therapy for colorectal cancer treatment. Cells. 2025;14(10):745.","journal-title":"Cells"},{"key":"578_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1544241","volume":"17","author":"D Shi","year":"2025","unstructured":"Shi D, Guo X, Ning Z, Zhang Y, Liu F, Liu M, et al. Review of FUNDC1-mediated mitochondrial autophagy in Alzheimer\u2019s disease. Front Aging Neurosci. 2025;17:1544241.","journal-title":"Front Aging Neurosci"},{"key":"578_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102114","volume":"92","author":"HM Mansour","year":"2023","unstructured":"Mansour HM, El-Khatib AS. Exploring Parkinson-associated kinases for CRISPR\/Cas9-based gene editing: beyond alpha-synuclein. Ageing Res Rev. 2023;92:102114.","journal-title":"Ageing Res Rev"},{"issue":"6","key":"578_CR31","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1002\/med.21718","volume":"40","author":"D Li","year":"2020","unstructured":"Li D, Mastaglia FL, Fletcher S, Wilton SD. Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson\u2019s disease in the precision medicine era. Med Res Rev. 2020;40(6):2650\u201381.","journal-title":"Med Res Rev"},{"key":"578_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116455","volume":"312","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Luo D, Shi J, Yang X, Xu W, Gao W, et al. Loganin alleviated cognitive impairment in 3\u00d7Tg-AD mice through promoting mitophagy mediated by optineurin. J Ethnopharmacol. 2023;312:116455.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"578_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12906-024-04403-7","volume":"24","author":"Y Yang","year":"2024","unstructured":"Yang Y, Chen W, Lin Z, Wu Y, Li Y, Xia X. Panax notoginseng saponins prevent dementia and oxidative stress in brains of SAMP8 mice by enhancing mitophagy. BMC Complement Med Ther. 2024;24(1):144.","journal-title":"BMC Complement Med Ther"},{"issue":"1","key":"578_CR34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s12035-022-03035-7","volume":"60","author":"N Zhao","year":"2023","unstructured":"Zhao N, Zhang X, Li B, Wang J, Zhang C, Xu B. Treadmill exercise improves PINK1\/Parkin-mediated mitophagy activity against Alzheimer\u2019s disease pathologies by upregulated SIRT1-FOXO1\/3 axis in APP\/PS1 mice. Mol Neurobiol. 2023;60(1):277\u201391.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"578_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41401-023-01144-0","volume":"45","author":"W Yu","year":"2024","unstructured":"Yu W, Wang L, Ren WY, Xu HX, Wu NN, Yu DH, et al. SGLT2 inhibitor empagliflozin alleviates cardiac remodeling and contractile anomalies in a FUNDC1-dependent manner in experimental Parkinson\u2019s disease. Acta Pharmacol Sin. 2024;45(1):87\u201397.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"578_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167617","volume":"1871","author":"C Pal","year":"2025","unstructured":"Pal C. Mitochondria-targeting by small molecules against Alzheimer\u2019s disease: a mechanistic perspective. Biochimica et Biophysica Acta (BBA) - Mol Basis Dis. 2025;1871(3):167617.","journal-title":"Biochimica et Biophysica Acta (BBA) - Mol Basis Dis"},{"issue":"3","key":"578_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, et al. Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat Neurosci. 2019;22(3):401\u201312.","journal-title":"Nat Neurosci"},{"issue":"1","key":"578_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41531-024-00696-0","volume":"10","author":"I Kinnart","year":"2024","unstructured":"Kinnart I, Manders L, Heyninck T, Imberechts D, Praschberger R, Schoovaerts N, et al. Elevated \u03b1-synuclein levels inhibit mitophagic flux. NPJ Parkinsons Dis. 2024;10(1):80.","journal-title":"NPJ Parkinsons Dis"},{"key":"578_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2022.105461","volume":"162","author":"P Sivakumar","year":"2023","unstructured":"Sivakumar P, Nagashanmugam KB, Priyatharshni S, Lavanya R, Prabhu N, Ponnusamy S. Review on the interactions between dopamine metabolites and \u03b1-Synuclein in causing Parkinson\u2019s disease. Neurochem Int. 2023;162:105461.","journal-title":"Neurochem Int"},{"issue":"1","key":"578_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06439-6","volume":"15","author":"J Okarmus","year":"2024","unstructured":"Okarmus J, Agergaard JB, Stummann TC, Haukedal H, Ambj\u00f8rn M, Freude KK, et al. USP30 inhibition induces mitophagy and reduces oxidative stress in parkin-deficient human neurons. Cell Death Dis. 2024;15(1):52.","journal-title":"Cell Death Dis"},{"issue":"1","key":"578_CR41","doi-asserted-by":"publisher","first-page":"7295","DOI":"10.1038\/s41467-023-42876-1","volume":"14","author":"TZ Fang","year":"2023","unstructured":"Fang TZ, Sun Y, Pearce AC, Eleuteri S, Kemp M, Luckhurst CA, et al. Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson\u2019s disease mouse model. Nat Commun. 2023;14(1):7295.","journal-title":"Nat Commun"},{"issue":"19","key":"578_CR42","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1002\/1873-3468.70118","volume":"599","author":"A R\u00f6ntgen","year":"2025","unstructured":"R\u00f6ntgen A, Toprakcioglu Z, Vendruscolo M. A\u03b242 promotes the aggregation of \u03b1-synuclein splice isoforms via heterogeneous nucleation. FEBS Lett. 2025;599(19):2750\u201367.","journal-title":"FEBS Lett"},{"issue":"30","key":"578_CR43","doi-asserted-by":"publisher","first-page":"8005","DOI":"10.1073\/pnas.1700239114","volume":"114","author":"S Chia","year":"2017","unstructured":"Chia S, Flagmeier P, Habchi J, Lattanzi V, Linse S, Dobson CM, et al. Monomeric and fibrillar \u03b1-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of A\u03b242 aggregates. Proc Natl Acad Sci U S A. 2017;114(30):8005\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"578_CR44","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.tips.2024.09.002","volume":"45","author":"KS Dhar","year":"2024","unstructured":"Dhar KS, Townsend B, Montgomery AP, Danon JJ, Pagan JK, Kassiou M. Enhancing CNS mitophagy: drug development and disease-relevant models. Trends Pharmacol Sci. 2024;45(11):982\u201396.","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"578_CR45","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","volume":"57","author":"M Ma","year":"2024","unstructured":"Ma M, Jiang W, Zhou R. DAMPs and DAMP-sensing receptors in inflammation and diseases. Immunity. 2024;57(4):752\u201371.","journal-title":"Immunity"},{"key":"578_CR46","doi-asserted-by":"crossref","unstructured":"Pr\u00f3chnicki T, Mangan MS, Latz E. Recent insights into the molecular mechanisms of the NLRP3 inflammasome activation. F1000Res. 2016;5:F1000 Faculty Rev-1469.","DOI":"10.12688\/f1000research.8614.1"},{"key":"578_CR47","first-page":"15","volume":"8","author":"E Ozaki","year":"2015","unstructured":"Ozaki E, Campbell M, Doyle SL. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives. J Inflamm Res. 2015;8:15\u201327.","journal-title":"J Inflamm Res"},{"key":"578_CR48","doi-asserted-by":"publisher","first-page":"1109938","DOI":"10.3389\/fimmu.2022.1109938","volume":"13","author":"X Zhan","year":"2022","unstructured":"Zhan X, Li Q, Xu G, Xiao X, Bai Z. The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors. Front Immunol. 2022;13:1109938.","journal-title":"Front Immunol"},{"issue":"1","key":"578_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41420-023-01783-6","volume":"10","author":"Y Si","year":"2024","unstructured":"Si Y, Liu L, Fan Z. Mechanisms and effects of NLRP3 in digestive cancers. Cell Death Discov. 2024;10(1):10.","journal-title":"Cell Death Discov"},{"issue":"1","key":"578_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13406","volume":"329","author":"A Pandey","year":"2025","unstructured":"Pandey A, Li Z, Gautam M, Ghosh A, Man SM. Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis. Immunol Rev. 2025;329(1):e13406.","journal-title":"Immunol Rev"},{"issue":"7","key":"578_CR51","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/icb.2017.23","volume":"95","author":"JK Kim","year":"2017","unstructured":"Kim JK, Jin HS, Suh HW, Jo EK. Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling. Immunol Cell Biol. 2017;95(7):584\u201392.","journal-title":"Immunol Cell Biol"},{"key":"578_CR52","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fimmu.2020.00211","volume":"11","author":"C Zhao","year":"2020","unstructured":"Zhao C, Zhao W. NLRP3 inflammasome-A key player in antiviral responses. Front Immunol. 2020;11:211.","journal-title":"Front Immunol"},{"issue":"1","key":"578_CR53","first-page":"120","volume":"16","author":"D Chu","year":"2024","unstructured":"Chu D, Zhao M, Rong S, Jhe W, Cai X, Xiao Y, et al. Dual-atom nanozyme eye drops attenuate inflammation and break the vicious cycle in dry eye disease. Nanomicro Lett. 2024;16(1):120.","journal-title":"Nanomicro Lett"},{"issue":"1","key":"578_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10753-024-02036-z","volume":"48","author":"X Wu","year":"2025","unstructured":"Wu X, Tian Y, Wang H, Chen H, Hou H, Hu Q. Dual regulation of nicotine on NLRP3 inflammasome in macrophages with the involvement of lysosomal destabilization, ROS and \u03b17nAChR. Inflammation. 2025;48(1):61\u201374.","journal-title":"Inflammation"},{"key":"578_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102515","volume":"113","author":"N Zhao","year":"2020","unstructured":"Zhao N, Li CC, Di B, Xu LL. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: mechanisms, role in diseases and related inhibitors. J Autoimmun. 2020;113:102515.","journal-title":"J Autoimmun"},{"issue":"12","key":"578_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121885","volume":"11","author":"Y Rajesh","year":"2022","unstructured":"Rajesh Y, Kanneganti TD. Innate immune cell death in neuroinflammation and Alzheimer\u2019s disease. Cells. 2022;11(12):1885.","journal-title":"Cells"},{"issue":"7","key":"578_CR57","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3233\/JPD-223290","volume":"12","author":"L Nguyen","year":"2022","unstructured":"Nguyen L, Nguyen HD, Kim YJ, Nguyen TT, Lai TT, Lee YK, et al. Role of NLRP3 inflammasome in Parkinson\u2019s disease and therapeutic considerations. J Parkinsons Dis. 2022;12(7):2117\u201333.","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"578_CR58","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s12264-023-01023-y","volume":"39","author":"QQ Han","year":"2023","unstructured":"Han QQ, Le W. NLRP3 Inflammasome-mediated neuroinflammation and related mitochondrial impairment in Parkinson\u2019s disease. Neurosci Bull. 2023;39(5):832\u201344.","journal-title":"Neurosci Bull"},{"issue":"2","key":"578_CR59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41582-023-00915-x","volume":"20","author":"KA Ravichandran","year":"2024","unstructured":"Ravichandran KA, Heneka MT. Inflammasomes in neurological disorders\u2013mechanisms and therapeutic potential. Nat Rev Neurol. 2024;20(2):67\u201383.","journal-title":"Nat Rev Neurol"},{"key":"578_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2021.05.008","volume":"349","author":"X Qiu","year":"2021","unstructured":"Qiu X, Wang Q, Hou L, Zhang C, Wang Q, Zhao X. Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson\u2019s disease model. Toxicol Lett. 2021;349:1\u201311.","journal-title":"Toxicol Lett"},{"issue":"1","key":"578_CR61","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12964-024-01504-1","volume":"22","author":"S Manshouri","year":"2024","unstructured":"Manshouri S, Seif F, Kamali M, Bahar MA, Mashayekh A, Molatefi R. The interaction of inflammasomes and gut microbiota: novel therapeutic insights. Cell Commun Signal. 2024;22(1):209.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"578_CR62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41577-024-01075-9","volume":"25","author":"RC Coll","year":"2025","unstructured":"Coll RC, Schroder K. Inflammasome components as new therapeutic targets in inflammatory disease. Nat Rev Immunol. 2025;25(1):22\u201341.","journal-title":"Nat Rev Immunol"},{"key":"578_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115915","volume":"218","author":"V Ramalingam","year":"2023","unstructured":"Ramalingam V. NLRP3 inhibitors: unleashing their therapeutic potential against inflammatory diseases. Biochem Pharmacol. 2023;218:115915.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"578_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-024-06306-1","volume":"68","author":"DT Meier","year":"2025","unstructured":"Meier DT, de Paula Souza J, Donath MY. Targeting the NLRP3 inflammasome-IL-1\u03b2 pathway in type 2 diabetes and obesity. Diabetologia. 2025;68(1):3\u201316.","journal-title":"Diabetologia"},{"issue":"3","key":"578_CR65","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","volume":"23","author":"S Marchi","year":"2023","unstructured":"Marchi S, Guilbaud E, Tait S, Yamazaki T, Galluzzi L. Mitochondrial control of inflammation. Nat Rev Immunol. 2023;23(3):159\u201373.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"578_CR66","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41380-022-01631-6","volume":"28","author":"A Mary","year":"2023","unstructured":"Mary A, Eysert F, Checler F, Chami M. Mitophagy in Alzheimer\u2019s disease: molecular defects and therapeutic approaches. Mol Psychiatry. 2023;28(1):202\u201316.","journal-title":"Mol Psychiatry"},{"key":"578_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115735","volume":"168","author":"Q Huang","year":"2023","unstructured":"Huang Q, Yang P, Liu Y, Ding J, Lu M, Hu G. The interplay between \u03b1-synuclein and NLRP3 inflammasome in Parkinson\u2019s disease. Biomed Pharmacother. 2023;168:115735.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"578_CR68","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1021\/acschemneuro.9b00260","volume":"10","author":"M Aftabizadeh","year":"2019","unstructured":"Aftabizadeh M, Tatarek-Nossol M, Andreetto E, El Bounkari O, Kipp M, Beyer C, et al. Blocking inflammasome activation caused by \u03b2-amyloid peptide (A\u03b2) and islet amyloid polypeptide (IAPP) through an IAPP mimic. ACS Chem Neurosci. 2019;10(8):3703\u201317.","journal-title":"ACS Chem Neurosci"},{"issue":"6","key":"578_CR69","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41556-024-01419-6","volume":"26","author":"H Liu","year":"2024","unstructured":"Liu H, Zhen C, Xie J, Luo Z, Zeng L, Zhao G, et al. TFAM is an autophagy receptor that limits inflammation by binding to cytoplasmic mitochondrial DNA. Nat Cell Biol. 2024;26(6):878\u201391.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"578_CR70","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","volume":"36","author":"K Shimada","year":"2012","unstructured":"Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. 2012;36(3):401\u201314.","journal-title":"Immunity"},{"key":"578_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108719","volume":"108","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Huang Y, Chen M, Yang Y, Li X, Zhang W. Mitochondrial DNA in NLRP3 inflammasome activation. Int Immunopharmacol. 2022;108:108719.","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"578_CR72","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","volume":"55","author":"H Xian","year":"2022","unstructured":"Xian H, Watari K, Sanchez-Lopez E, Offenberger J, Onyuru J, Sampath H, et al. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity. 2022;55(8):1370-85.e8.","journal-title":"Immunity"},{"key":"578_CR73","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.4c00057","author":"M Kumari","year":"2024","unstructured":"Kumari M, Bisht KS, Ahuja K, Motiani RK, Maiti TK. Glycation produces topologically different \u03b1-synuclein oligomeric strains and modulates microglia response via the NLRP3-inflammasome pathway. ACS Chem Neurosci. 2024. https:\/\/doi.org\/10.1021\/acschemneuro.4c00057.","journal-title":"ACS Chem Neurosci"},{"issue":"15","key":"578_CR74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2025847118","volume":"118","author":"D Trudler","year":"2021","unstructured":"Trudler D, Nazor KL, Eisele YS, Grabauskas T, Dolatabadi N, Parker J, et al. Soluble \u03b1-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia. Proc Natl Acad Sci U S A. 2021;118(15):e2025847118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"578_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134714","volume":"21","author":"JM Yuk","year":"2020","unstructured":"Yuk JM, Silwal P, Jo EK. Inflammasome and mitophagy connection in health and disease. Int J Mol Sci. 2020;21(13):4714.","journal-title":"Int J Mol Sci"},{"key":"578_CR76","volume":"2023","author":"O Hamzeh","year":"2023","unstructured":"Hamzeh O, Rabiei F, Shakeri M, Parsian H, Saadat P, Rostami-Mansoor S. Mitochondrial dysfunction and inflammasome activation in neurodegenerative diseases: mechanisms and therapeutic implications. Mitochondrion.\u00a02023:S1567-7249(23)00087-9.","journal-title":"Mitochondrion"},{"key":"578_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175300","volume":"934","author":"M Khot","year":"2022","unstructured":"Khot M, Sood A, Tryphena KP, Khan S, Srivastava S, Singh SB, et al. NLRP3 inflammasomes: a potential target to improve mitochondrial biogenesis in Parkinson\u2019s disease. Eur J Pharmacol. 2022;934:175300.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"578_CR78","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12974-021-02349-y","volume":"18","author":"J Chen","year":"2021","unstructured":"Chen J, Mao K, Yu H, Wen Y, She H, Zhang H, et al. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson\u2019s disease. J Neuroinflammation. 2021;18(1):295.","journal-title":"J Neuroinflammation"},{"key":"578_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.629891","volume":"13","author":"W Zhou","year":"2021","unstructured":"Zhou W, Xiao D, Zhao Y, Tan B, Long Z, Yu L, et al. Enhanced autolysosomal function ameliorates the inflammatory response mediated by the NLRP3 inflammasome in Alzheimer\u2019s disease. Front Aging Neurosci. 2021;13:629891.","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"578_CR80","first-page":"1221","volume":"14","author":"A Litwiniuk","year":"2021","unstructured":"Litwiniuk A, Baranowska-Bik A, Doma\u0144ska A, Kalisz M, Bik W. Contribution of mitochondrial dysfunction combined with NLRP3 inflammasome activation in selected neurodegenerative diseases. Pharm (Basel). 2021;14(12):1221.","journal-title":"Pharm (Basel)"},{"issue":"15","key":"578_CR81","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","volume":"110","author":"N Panicker","year":"2022","unstructured":"Panicker N, Kam TI, Wang H, Neifert S, Chou SC, Kumar M, et al. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson\u2019s disease. Neuron. 2022;110(15):2422-37.e9.","journal-title":"Neuron"},{"issue":"1","key":"578_CR82","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12974-023-02709-w","volume":"20","author":"R Zheng","year":"2023","unstructured":"Zheng R, Yan Y, Dai S, Ruan Y, Chen Y, Hu C, et al. ASC specks exacerbate \u03b1-synuclein pathology via amplifying NLRP3 inflammasome activities. J Neuroinflammation. 2023;20(1):26.","journal-title":"J Neuroinflammation"},{"key":"578_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102279","volume":"96","author":"A Kaushik","year":"2024","unstructured":"Kaushik A, Parashar S, Ambasta RK, Kumar P. Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing pathways in neurodegenerative disorders and cancer. Ageing Res Rev. 2024;96:102279.","journal-title":"Ageing Res Rev"},{"key":"578_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102078","volume":"91","author":"ML Hu","year":"2023","unstructured":"Hu ML, Pan YR, Yong YY, Liu Y, Yu L, Qin DL, et al. Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: Past, present, and future. Ageing Res Rev. 2023;91:102078.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"578_CR85","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9(1):42.","journal-title":"Transl Neurodegener"},{"key":"578_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101973","volume":"200","author":"H Franklin","year":"2021","unstructured":"Franklin H, Clarke BE, Patani R. Astrocytes and microglia in neurodegenerative diseases: lessons from human in vitro models. Prog Neurobiol. 2021;200:101973.","journal-title":"Prog Neurobiol"},{"issue":"10","key":"578_CR87","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.2174\/1570159X21666221129121715","volume":"21","author":"A Bhusal","year":"2023","unstructured":"Bhusal A, Afridi R, Lee WH, Suk K. Bidirectional communication between microglia and astrocytes in neuroinflammation. Curr Neuropharmacol. 2023;21(10):2020\u20139.","journal-title":"Curr Neuropharmacol"},{"key":"578_CR88","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6052932","volume":"2022","author":"DM Sumsuzzman","year":"2022","unstructured":"Sumsuzzman DM, Uddin MS, Kabir MT, Hasana S, Perveen A, Alanazi IS, et al. Microglia in Alzheimer\u2019s disease: a favorable cellular target to ameliorate Alzheimer\u2019s pathogenesis. Mediators Inflamm. 2022;2022:6052932.","journal-title":"Mediators Inflamm"},{"key":"578_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106404","volume":"184","author":"A Yousefizadeh","year":"2022","unstructured":"Yousefizadeh A, Piccioni G, Saidi A, Triaca V, Mango D, Nistic\u00f2 R. Pharmacological targeting of microglia dynamics in Alzheimer\u2019s disease: preclinical and clinical evidence. Pharmacol Res. 2022;184:106404.","journal-title":"Pharmacol Res"},{"issue":"1","key":"578_CR90","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12974-025-03420-8","volume":"22","author":"K Chen","year":"2025","unstructured":"Chen K, Li F, Zhang S, Chen Y, Ikezu TC, Li Z, et al. Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. J Neuroinflammation. 2025;22(1):93.","journal-title":"J Neuroinflammation"},{"key":"578_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2025.115205","volume":"388","author":"XQ Peng","year":"2025","unstructured":"Peng XQ, Guo HS, Zhang X, Wu XY, Ruganzu JB, Wu SD, et al. TREM2 promotes hippocampal neurogenesis through regulating microglial M2 polarization in APP\/PS1 mice. Exp Neurol. 2025;388:115205.","journal-title":"Exp Neurol"},{"key":"578_CR92","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fncel.2018.00206","volume":"12","author":"H Konishi","year":"2018","unstructured":"Konishi H, Kiyama H. Microglial TREM2\/DAP12 signaling: a double-edged sword in neural diseases. Front Cell Neurosci. 2018;12:206.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"578_CR93","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11064-025-04375-1","volume":"50","author":"F Cao","year":"2025","unstructured":"Cao F, Zhang P, Chi Y, Wang Y, Xu L, Zhang D. Celastrol ameliorated Alzheimer\u2019s disease in mice by enhancing TBX21\/TREM2 expression in microglia and inhibiting tau phosphorylation. Neurochem Res. 2025;50(2):126.","journal-title":"Neurochem Res"},{"issue":"20","key":"578_CR94","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.3390\/nu16203558","volume":"16","author":"D Wang","year":"2024","unstructured":"Wang D, Liu J, Zhu Q, Wei X, Zhang X, Chen Q, et al. Ouabain ameliorates Alzheimer\u2019s disease-associated neuropathology and cognitive impairment in FAD(4T) mice. Nutrients. 2024;16(20):3558.","journal-title":"Nutrients"},{"issue":"1","key":"578_CR95","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/cmi.2008.2","volume":"5","author":"JH Lu","year":"2008","unstructured":"Lu JH, Teh BK, Ld W, Wang YN, Tan YS, Lai MC, et al. The classical and regulatory functions of C1q in immunity and autoimmunity. Cell Mol Immunol. 2008;5(1):9\u201321.","journal-title":"Cell Mol Immunol"},{"issue":"21","key":"578_CR96","doi-asserted-by":"publisher","first-page":"eabq7806","DOI":"10.1126\/sciadv.abq7806","volume":"9","author":"HY Chung","year":"2023","unstructured":"Chung HY, Wickel J, Hahn N, Mein N, Schwarzbrunn M, Koch P, et al. Microglia mediate neurocognitive deficits by eliminating C1q-tagged synapses in sepsis-associated encephalopathy. Sci Adv. 2023;9(21):eabq7806.","journal-title":"Sci Adv"},{"issue":"1","key":"578_CR97","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12974-025-03528-x","volume":"22","author":"Y Yu","year":"2025","unstructured":"Yu Y, Xiao W, Ma Z, Yi X, Zhong T, Li Z. Circulatory extracellular vesicles transport complement C1q for promoting neuronal amyloid-\u03b2 production in Alzheimer\u2019s disease. J Neuroinflammation. 2025;22(1):209.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"578_CR98","doi-asserted-by":"publisher","first-page":"e70009","DOI":"10.1111\/jns.70009","volume":"30","author":"QD Mohammad","year":"2025","unstructured":"Mohammad QD, Islam Z, Papri N, Hayat S, Jahan I, Azad K, et al. Results from a Phase 1 study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of ANX005, a C1q inhibitor, in patients with guillain-barr\u00e9 syndrome. J Peripher Nerv Syst. 2025;30(1):e70009.","journal-title":"J Peripher Nerv Syst"},{"issue":"6","key":"578_CR99","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/1091581817740873","volume":"36","author":"JA Lansita","year":"2017","unstructured":"Lansita JA, Mease KM, Qiu H, Yednock T, Sankaranarayanan S, Kramer S. Nonclinical development of ANX005: a humanized anti-C1q antibody for treatment of autoimmune and neurodegenerative diseases. Int J Toxicol. 2017;36(6):449\u201362.","journal-title":"Int J Toxicol"},{"issue":"4","key":"578_CR100","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41419-023-05807-y","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang W, Ding L, Chen H, Zhang M, Ma R, Zheng S, et al. Cntnap4 partial deficiency exacerbates \u03b1-synuclein pathology through astrocyte-microglia C3\u2013C3aR pathway. Cell Death Dis. 2023;14(4):285.","journal-title":"Cell Death Dis"},{"issue":"9","key":"578_CR101","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.ymthe.2023.07.017","volume":"31","author":"L Xu","year":"2023","unstructured":"Xu L, Xu H, Chen S, Jiang W, Afridi SK, Wang Y, et al. Inhibition of complement C3 signaling ameliorates locomotor and visual dysfunction in autoimmune inflammatory diseases. Mol Ther. 2023;31(9):2715\u201333.","journal-title":"Mol Ther"},{"issue":"1","key":"578_CR102","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12974-021-02225-9","volume":"18","author":"E Gregersen","year":"2021","unstructured":"Gregersen E, Betzer C, Kim WS, Kovacs G, Reimer L, Halliday GM, et al. Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity. J Neuroinflammation. 2021;18(1):177.","journal-title":"J Neuroinflammation"},{"issue":"Suppl","key":"578_CR103","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"CA Ross","year":"2004","unstructured":"Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;10(Suppl):S10\u20137.","journal-title":"Nat Med"},{"issue":"11","key":"578_CR104","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.1002\/alz.14225","volume":"20","author":"A Pichet Binette","year":"2024","unstructured":"Pichet Binette A, Mammana A, Wisse L, Rossi M, Strandberg O, Smith R, et al. Associations between misfolded alpha-synuclein aggregates and Alzheimer\u2019s disease pathology in vivo. Alzheimers Dement. 2024;20(11):7624\u201334.","journal-title":"Alzheimers Dement"},{"key":"578_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106889","volume":"209","author":"YB Mingo","year":"2025","unstructured":"Mingo YB, Escobar Galvis ML, Henderson MX. \u03b1-Synuclein pathology and mitochondrial dysfunction: toxic partners in Parkinson\u2019s disease. Neurobiol Dis. 2025;209:106889.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"578_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47040259","volume":"47","author":"N Brezic","year":"2025","unstructured":"Brezic N, Gligorevic S, Sic A, Knezevic NN. Protein misfolding and aggregation as a mechanistic link between chronic pain and neurodegenerative diseases. Curr Issues Mol Biol. 2025;47(4):259.","journal-title":"Curr Issues Mol Biol"},{"issue":"6","key":"578_CR107","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70363","volume":"21","author":"VZ Lau","year":"2025","unstructured":"Lau VZ, Awogbindin IO, Frenkel D, Whitehead SN, Tremblay M\u00c8. A hypothesis explaining Alzheimer\u2019s disease, Parkinson\u2019s disease, and dementia with Lewy bodies overlap. Alzheimers Dement. 2025;21(6):e70363.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"578_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s12575-024-00236-3","volume":"26","author":"H Li","year":"2024","unstructured":"Li H, Zhang J, Shen Y, Ye Y, Jiang Q, Chen L, et al. Targeting mitochondrial complex I deficiency in MPP(+)\/MPTP-induced Parkinson\u2019s disease cell culture and mouse models by transducing yeast NDI1 gene. Biol Proced Online. 2024;26(1):9.","journal-title":"Biol Proced Online"},{"issue":"7","key":"578_CR109","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1093\/brain\/awae092","volume":"147","author":"C Hung","year":"2024","unstructured":"Hung C, Fertan E, Livesey FJ, Klenerman D, Patani R. APP antisense oligonucleotides reduce amyloid-\u03b2 aggregation and rescue endolysosomal dysfunction in Alzheimer\u2019s disease. Brain. 2024;147(7):2325\u201333.","journal-title":"Brain"},{"issue":"10","key":"578_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/biom13101435","volume":"13","author":"L Nechushtai","year":"2023","unstructured":"Nechushtai L, Frenkel D, Pinkas-Kramarski R. Autophagy in Parkinson\u2019s disease. Biomolecules. 2023;13(10):1435.","journal-title":"Biomolecules"},{"issue":"6","key":"578_CR111","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41593-022-01084-8","volume":"25","author":"JH Lee","year":"2022","unstructured":"Lee JH, Yang DS, Goulbourne CN, Im E, Stavrides P, Pensalfini A, et al. Faulty autolysosome acidification in Alzheimer\u2019s disease mouse models induces autophagic build-up of A\u03b2 in neurons, yielding senile plaques. Nat Neurosci. 2022;25(6):688\u2013701.","journal-title":"Nat Neurosci"},{"issue":"7","key":"578_CR112","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04389-w","volume":"79","author":"M Rajendran","year":"2022","unstructured":"Rajendran M, Queralt-Mart\u00edn M, Gurnev PA, Rosencrans WM, Rovini A, Jacobs D, et al. Restricting \u03b1-synuclein transport into mitochondria by inhibition of \u03b1-synuclein-VDAC complexation as a potential therapeutic target for Parkinson\u2019s disease treatment. Cell Mol Life Sci. 2022;79(7):368.","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"578_CR113","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1080\/15548627.2022.2110729","volume":"18","author":"JH Lee","year":"2022","unstructured":"Lee JH, Nixon RA. Autolysosomal acidification failure as a primary driver of Alzheimer disease pathogenesis. Autophagy. 2022;18(11):2763\u20134.","journal-title":"Autophagy"},{"issue":"5","key":"578_CR114","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1080\/15548627.2023.2281134","volume":"20","author":"JJ Wu","year":"2024","unstructured":"Wu JJ, Yu H, Bi SG, Wang ZX, Gong J, Mao YM, et al. Aerobic exercise attenuates autophagy-lysosomal flux deficits by ADRB2\/\u03b22-adrenergic receptor-mediated V-ATPase assembly factor VMA21 signaling in APP-PSEN1\/PS1 mice. Autophagy. 2024;20(5):1015\u201331.","journal-title":"Autophagy"},{"issue":"30","key":"578_CR115","doi-asserted-by":"publisher","first-page":"eadg1925","DOI":"10.1126\/sciadv.adg1925","volume":"9","author":"E Im","year":"2023","unstructured":"Im E, Jiang Y, Stavrides PH, Darji S, Erdjument-Bromage H, Neubert TA, et al. Lysosomal dysfunction in Down syndrome and Alzheimer mouse models is caused by v-ATPase inhibition by Tyr(682)-phosphorylated APP \u03b2CTF. Sci Adv. 2023;9(30):eadg1925.","journal-title":"Sci Adv"},{"key":"578_CR116","doi-asserted-by":"publisher","first-page":"1490275","DOI":"10.3389\/fmolb.2024.1490275","volume":"11","author":"A Man\u00e7ano","year":"2024","unstructured":"Man\u00e7ano A, Pina JG, Froes BR, Sciani JM. Autophagy-lysosomal pathway impairment and cathepsin dysregulation in Alzheimer\u2019s disease. Front Mol Biosci. 2024;11:1490275.","journal-title":"Front Mol Biosci"},{"issue":"3","key":"578_CR117","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s12276-023-00965-7","volume":"55","author":"J Kim","year":"2023","unstructured":"Kim J, Kim HS, Chung JH. Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway. Exp Mol Med. 2023;55(3):510\u20139.","journal-title":"Exp Mol Med"},{"issue":"5","key":"578_CR118","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3390\/biom12050655","volume":"12","author":"C Chavarr\u00eda","year":"2022","unstructured":"Chavarr\u00eda C, Ivagnes R, Souza JM. Extracellular alpha-synuclein: mechanisms for glial cell internalization and activation. Biomolecules. 2022;12(5):655.","journal-title":"Biomolecules"},{"issue":"15","key":"578_CR119","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2118819119","volume":"119","author":"JT Hinkle","year":"2022","unstructured":"Hinkle JT, Patel J, Panicker N, Karuppagounder SS, Biswas D, Belingon B, et al. STING mediates neurodegeneration and neuroinflammation in nigrostriatal \u03b1-synucleinopathy. Proc Natl Acad Sci U S A. 2022;119(15):e2118819119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt A","key":"578_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110827","volume":"124","author":"B Wang","year":"2023","unstructured":"Wang B, Wang Y, Qiu J, Gao S, Yu S, Sun D, et al. The STING inhibitor C-176 attenuates MPTP-induced neuroinflammation and neurodegeneration in mouse parkinsonian models. Int Immunopharmacol. 2023;124(Pt A):110827.","journal-title":"Int Immunopharmacol"},{"key":"578_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114791","volume":"244","author":"X Tian","year":"2022","unstructured":"Tian X, Xu F, Zhu Q, Feng Z, Dai W, Zhou Y, et al. Medicinal chemistry perspective on cGAS-STING signaling pathway with small molecule inhibitors. Eur J Med Chem. 2022;244:114791.","journal-title":"Eur J Med Chem"},{"issue":"15","key":"578_CR122","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.neuron.2022.06.015","volume":"110","author":"KE Zengeler","year":"2022","unstructured":"Zengeler KE, Lukens JR. Taking the parkin brakes off of neuronal NLRP3 drives inflammasome activation and neurodegeneration in Parkinson\u2019s disease. Neuron. 2022;110(15):2356\u20138.","journal-title":"Neuron"},{"key":"578_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.957705","volume":"14","author":"Q Su","year":"2022","unstructured":"Su Q, Ng WL, Goh SY, Gulam MY, Wang LF, Tan EK, et al. Targeting the inflammasome in Parkinson\u2019s disease. Front Aging Neurosci. 2022;14:957705.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"578_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202207719","volume":"35","author":"M Jung","year":"2023","unstructured":"Jung M, Lee S, Park S, Hong J, Kim C, Cho I, et al. A therapeutic nanovaccine that generates anti-amyloid antibodies and amyloid-specific regulatory T cells for Alzheimer\u2019s disease. Adv Mater. 2023;35(3):e2207719.","journal-title":"Adv Mater"},{"issue":"5","key":"578_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103547","volume":"28","author":"K Kalani","year":"2023","unstructured":"Kalani K, Chaturvedi P, Chaturvedi P, Kumar Verma V, Lal N, Awasthi SK, et al. Mitochondrial mechanisms in Alzheimer\u2019s disease: quest for therapeutics. Drug Discov Today. 2023;28(5):103547.","journal-title":"Drug Discov Today"},{"issue":"6","key":"578_CR126","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1002\/alz.13847","volume":"20","author":"Y Hou","year":"2024","unstructured":"Hou Y, Chu X, Park JH, Zhu Q, Hussain M, Li Z, et al. Urolithin A improves Alzheimer\u2019s disease cognition and restores mitophagy and lysosomal functions. Alzheimers Dement. 2024;20(6):4212\u201333.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"578_CR127","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1039\/D1FO02534A","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Jiang J, Qiu J, Wang L, Zhuo J, Wang B, et al. Urolithin A protects dopaminergic neurons in experimental models of Parkinson\u2019s disease by promoting mitochondrial biogenesis through the SIRT1\/PGC-1\u03b1 signaling pathway. Food Funct. 2022;13(1):375\u201385.","journal-title":"Food Funct"},{"issue":"4","key":"578_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043398","volume":"24","author":"R Zhang","year":"2023","unstructured":"Zhang R, Lu J, Pei G, Huang S. Galangin rescues Alzheimer\u2019s amyloid-\u03b2 induced mitophagy and brain organoid growth impairment. Int J Mol Sci. 2023;24(4):3398.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"578_CR129","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3390\/antiox14121434","volume":"14","author":"HD Lin","year":"2025","unstructured":"Lin HD, Tsai RK, Wen YT, Liu PK. HDGF protects retinal pigment epithelium from glyoxal-induced ferroptosis via SIRT1\/PGC-1\u03b1\/Nrf2 pathway. Antioxidants (Basel). 2025;14(12):1434.","journal-title":"Antioxidants (Basel)"},{"key":"578_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101985","volume":"89","author":"S Abokyi","year":"2023","unstructured":"Abokyi S, Ghartey-Kwansah G, Tse DY. TFEB is a central regulator of the aging process and age-related diseases. Ageing Res Rev. 2023;89:101985.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"578_CR131","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","volume":"8","author":"S Wang","year":"2023","unstructured":"Wang S, Long H, Hou L, Feng B, Ma Z, Wu Y, et al. The mitophagy pathway and its implications in human diseases. Signal Transduct Target Ther. 2023;8(1):304.","journal-title":"Signal Transduct Target Ther"},{"issue":"23","key":"578_CR132","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1016\/j.scib.2023.10.021","volume":"68","author":"S Tan","year":"2023","unstructured":"Tan S, Wang D, Fu Y, Zheng H, Liu Y, Lu B. Targeted clearance of mitochondria by an autophagy-tethering compound (ATTEC) and its potential therapeutic effects. Sci Bull. 2023;68(23):3013\u201326.","journal-title":"Sci Bull"},{"issue":"8","key":"578_CR133","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1080\/15548627.2024.2340408","volume":"20","author":"K Veverov\u00e1","year":"2024","unstructured":"Veverov\u00e1 K, Lacz\u00f3 J, Katonov\u00e1 A, Hor\u00e1kov\u00e1 H, Matu\u0161kov\u00e1 V, Angelucci F, et al. Alterations of human CSF and serum-based mitophagy biomarkers in the continuum of Alzheimer disease. Autophagy. 2024;20(8):1868\u201378.","journal-title":"Autophagy"},{"issue":"6","key":"578_CR134","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D, Massey NL, et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol. 2019;15(6):556\u20139.","journal-title":"Nat Chem Biol"},{"key":"578_CR135","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbi.2023.11.031","volume":"116","author":"A Naeem","year":"2024","unstructured":"Naeem A, Prakash R, Kumari N, Ali Khan M, Quaiyoom Khan A, Uddin S, et al. MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer\u2019s disease. Brain Behav Immun. 2024;116:70\u201384.","journal-title":"Brain Behav Immun"},{"key":"578_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177774","volume":"1001","author":"H Gao","year":"2025","unstructured":"Gao H, Liang Y, Wang M, Li W, Zheng W, Wang Z, et al. Inhibition of \u03b1-synuclein aggregation by MCC950 attenuates dopaminergic neuronal damage in MN9D cells. Eur J Pharmacol. 2025;1001:177774.","journal-title":"Eur J Pharmacol"},{"issue":"21","key":"578_CR137","doi-asserted-by":"publisher","first-page":"14897","DOI":"10.1021\/acs.jmedchem.3c01398","volume":"66","author":"D Harrison","year":"2023","unstructured":"Harrison D, Billinton A, Bock MG, Doedens JR, Gabel CA, Holloway MK, et al. Discovery of clinical candidate NT-0796, a brain-penetrant and highly potent NLRP3 inflammasome inhibitor for neuroinflammatory disorders. J Med Chem. 2023;66(21):14897\u2013911.","journal-title":"J Med Chem"},{"issue":"22","key":"578_CR138","doi-asserted-by":"publisher","first-page":"10534","DOI":"10.1111\/jcmm.16984","volume":"25","author":"C Han","year":"2021","unstructured":"Han C, Hu Q, Yu A, Jiao Q, Yang Y. Mafenide derivatives inhibit neuroinflammation in Alzheimer\u2019s disease by regulating pyroptosis. J Cell Mol Med. 2021;25(22):10534\u201342.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"578_CR139","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13789","volume":"17","author":"E Gatlik","year":"2024","unstructured":"Gatlik E, Mehes B, Voltz E, Sommer U, Tritto E, Lestini G, et al. First-in-human safety, tolerability, and pharmacokinetic results of DFV890, an oral low-molecular-weight NLRP3 inhibitor. Clin Transl Sci. 2024;17(5):e13789.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"578_CR140","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41392-023-01687-y","volume":"9","author":"J Yao","year":"2024","unstructured":"Yao J, Sterling K, Wang Z, Zhang Y, Song W. The role of inflammasomes in human diseases and their potential as therapeutic targets. Signal Transduct Target Ther. 2024;9(1):10.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"578_CR141","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1021\/acsmedchemlett.4c00056","volume":"15","author":"RB Kargbo","year":"2024","unstructured":"Kargbo RB. Advancements in predictive medicine: NLRP3 inflammasome inhibitors and AI-driven predictive health analytics. ACS Med Chem Lett. 2024;15(3):331\u20133.","journal-title":"ACS Med Chem Lett"},{"key":"578_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.148959","volume":"1837","author":"Y Xie","year":"2024","unstructured":"Xie Y, Li X, Shi Q, Le L, Wang C, Xu H, et al. The synergistic effect of curcumin and mitoquinol mesylate on cognitive impairment and the neuropathology of Alzheimer\u2019s disease. Brain Res. 2024;1837:148959.","journal-title":"Brain Res"},{"issue":"19","key":"578_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197337","volume":"21","author":"TL Broderick","year":"2020","unstructured":"Broderick TL, Rasool S, Li R, Zhang Y, Anderson M, Al-Nakkash L, et al. Neuroprotective effects of chronic resveratrol treatment and exercise training in the 3xTg-AD mouse model of Alzheimer\u2019s disease. Int J Mol Sci. 2020;21(19):7337.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"578_CR144","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/iub.2902","volume":"76","author":"L Ozpak","year":"2024","unstructured":"Ozpak L, Ba\u011fca BG. Neuroprotective effects of resveratrol through modulation of PI3K\/Akt\/GSK-3\u03b2 pathway and metalloproteases. IUBMB Life. 2024;76(12):1199\u2013208.","journal-title":"IUBMB Life"},{"issue":"5","key":"578_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100633","volume":"3","author":"A Singh","year":"2022","unstructured":"Singh A, D\u2019Amico D, Andreux PA, Fouassier AM, Blanco-Bose W, Evans M, et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Rep Med. 2022;3(5):100633.","journal-title":"Cell Rep Med"},{"issue":"11","key":"578_CR146","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.7150\/thno.105953","volume":"15","author":"SJ Oh","year":"2025","unstructured":"Oh SJ, Kim YY, Ma R, Choi ST, Choi SM, Cho JH, et al. Pharmacological targeting of mitophagy via ALT001 improves herpes simplex virus 1 (HSV1)-mediated microglial inflammation and promotes amyloid \u03b2 phagocytosis by restricting HSV1 infection. Theranostics. 2025;15(11):4890\u2013908.","journal-title":"Theranostics"},{"issue":"4","key":"578_CR147","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s11064-025-04438-3","volume":"50","author":"SR Abd El-Khalik","year":"2025","unstructured":"Abd El-Khalik SR, AbuoHashish NA, Nasif E, Arakeep HM, El-Anwar N, Yousef DM, et al. Possible mitigating effect of nobiletin on rotenone-induced parkinsonism in male albino rat model: targeting Bmal1\/Nrf2 mediated ferroptosis and restoring mitochondrial mitophagy. Neurochem Res. 2025;50(4):208.","journal-title":"Neurochem Res"},{"issue":"6","key":"578_CR148","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12272-025-01550-4","volume":"48","author":"HB Yang","year":"2025","unstructured":"Yang HB, Lee CH, Nhung NT, Hung SY. Oleanolic acid activates the JNK-Sp1-DJ-1 axis to promote mitophagy-mediated neuroprotection in dopaminergic neurons for Parkinson\u2019s disease treatment. Arch Pharm Res. 2025;48(6):528\u201348.","journal-title":"Arch Pharm Res"},{"issue":"6","key":"578_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115809","volume":"44","author":"JH Howden","year":"2025","unstructured":"Howden JH, Hakansson H, Nieto-Rostro M, McAdam R, Arber C, Brandon NJ, et al. Hexokinase 2 interacts with PINK1 to facilitate mitophagy in astrocytes and restrain inflammation-induced neurotoxicity. Cell Rep. 2025;44(6):115809.","journal-title":"Cell Rep"},{"key":"578_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119988","volume":"350","author":"K Pu","year":"2025","unstructured":"Pu K, Yang S, Sheng R, Chen J, Dai Y, Wood IC, et al. Chuanxiong-Danggui herb pair alleviated cognitive deficits of APP\/PS1 mice by promoting mitophagy. J Ethnopharmacol. 2025;350:119988.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"578_CR151","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/bph.17373","volume":"182","author":"G Tao","year":"2025","unstructured":"Tao G, Wang X, Wang J, Ye Y, Zhang M, Lang Y, et al. Dihydro-resveratrol ameliorates NLRP3 inflammasome-mediated neuroinflammation via Bnip3-dependent mitophagy in Alzheimer\u2019s disease. Br J Pharmacol. 2025;182(4):1005\u201324.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"578_CR152","doi-asserted-by":"publisher","first-page":"e70346","DOI":"10.1111\/cns.70346","volume":"31","author":"Y Wang","year":"2025","unstructured":"Wang Y, Ge Y, Hua S, Shen C, Cai B, Zhao H. Aloe-emodin improves mitophagy in Alzheimer\u2019s disease via activating the AMPK\/PGC-1\u03b1\/SIRT3 signaling pathway. CNS Neurosci Ther. 2025;31(3):e70346.","journal-title":"CNS Neurosci Ther"},{"issue":"12","key":"578_CR153","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1080\/15548627.2024.2383145","volume":"20","author":"J Yi","year":"2024","unstructured":"Yi J, Wang HL, Lu G, Zhang H, Wang L, Li ZY, et al. Spautin-1 promotes PINK1-PRKN-dependent mitophagy and improves associative learning capability in an alzheimer disease animal model. Autophagy. 2024;20(12):2655\u201376.","journal-title":"Autophagy"},{"key":"578_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155298","volume":"124","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhao Q, Zhang Y, Di L, Xue F, Xu W, et al. A new andrographolide derivative ADA targeting SIRT3-FOXO3a signaling mitigates cognitive impairment by activating mitophagy and inhibiting neuroinflammation in Apoe4 mice. Phytomedicine. 2024;124:155298.","journal-title":"Phytomedicine"},{"key":"578_CR155","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.freeradbiomed.2025.01.014","volume":"228","author":"N Zheng","year":"2025","unstructured":"Zheng N, Cao RL, Liu DY, Liu P, Zhao XY, Zhang SX, et al. OAB-14 alleviates mitochondrial impairment through the SIRT3-dependent mechanism in APP\/PS1 transgenic mice and N2a\/APP cells. Free Radic Biol Med. 2025;228:360\u201378.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"578_CR156","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1038\/s41467-018-06449-x","volume":"9","author":"J Flores","year":"2018","unstructured":"Flores J, No\u00ebl A, Foveau B, Lynham J, Lecrux C, LeBlanc AC. Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer\u2019s disease mouse model. Nat Commun. 2018;9(1):3916.","journal-title":"Nat Commun"},{"issue":"50","key":"578_CR157","doi-asserted-by":"publisher","first-page":"32145","DOI":"10.1073\/pnas.2009680117","volume":"117","author":"N Lonnemann","year":"2020","unstructured":"Lonnemann N, Hosseini S, Marchetti C, Skouras DB, Stefanoni D, D\u2019Alessandro A, et al. The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2020;117(50):32145\u201354.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"s1","key":"578_CR158","doi-asserted-by":"publisher","first-page":"S345","DOI":"10.3233\/JAD-240495","volume":"101","author":"M Tahmi","year":"2024","unstructured":"Tahmi M, Benitez R, Luchsinger JA. Metformin as a potential prevention strategy for Alzheimer\u2019s disease and Alzheimer\u2019s disease related dementias. J Alzheimers Dis. 2024;101(s1):S345-345S356.","journal-title":"J Alzheimers Dis"},{"key":"578_CR159","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.bbi.2017.12.009","volume":"69","author":"Z Ou","year":"2018","unstructured":"Ou Z, Kong X, Sun X, He X, Zhang L, Gong Z, et al. Metformin treatment prevents amyloid plaque deposition and memory impairment in APP\/PS1 mice. Brain Behav Immun. 2018;69:351\u201363.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"578_CR160","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s40266-022-00923-4","volume":"39","author":"J Tosatti","year":"2022","unstructured":"Tosatti J, Fontes A, Caramelli P, Gomes KB. Effects of resveratrol supplementation on the cognitive function of patients with Alzheimer\u2019s disease: a systematic review of randomized controlled trials. Drugs Aging. 2022;39(4):285\u201395.","journal-title":"Drugs Aging"},{"issue":"5","key":"578_CR161","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.13875","volume":"5","author":"C Schwarz","year":"2022","unstructured":"Schwarz C, Benson GS, Horn N, Wurdack K, Grittner U, Schilling R, et al. Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline: a randomized clinical trial. JAMA Netw Open. 2022;5(5):e2213875.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"578_CR162","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02534-7","volume":"19","author":"K Freitag","year":"2022","unstructured":"Freitag K, Sterczyk N, Wendlinger S, Obermayer B, Schulz J, Farztdinov V, et al. Spermidine reduces neuroinflammation and soluble amyloid beta in an Alzheimer\u2019s disease mouse model. J Neuroinflammation. 2022;19(1):172.","journal-title":"J Neuroinflammation"},{"key":"578_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112918","volume":"149","author":"JA Pradeepkiran","year":"2022","unstructured":"Pradeepkiran JA, Hindle A, Kshirsagar S, Reddy PH. Are mitophagy enhancers therapeutic targets for Alzheimer\u2019s disease. Biomed Pharmacother. 2022;149:112918.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"578_CR164","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14671","volume":"30","author":"X Guo","year":"2024","unstructured":"Guo X, Yang L, Wang J, Wu Y, Li Y, Du L, et al. The cytosolic DNA-sensing cGAS-STING pathway in neurodegenerative diseases. CNS Neurosci Ther. 2024;30(3):e14671.","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"578_CR165","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/mds.70103","volume":"41","author":"AM Marinescu","year":"2026","unstructured":"Marinescu AM, Machado V, Pagano G, Muelhardt NM, Kustermann T, Mracsko EZ, et al. Cerebrospinal fluid biomarkers of NLRP3 pathway, immune dysregulation, and neurodegeneration in Parkinson\u2019s disease: a meta-analysis. Mov Disord. 2026;41(2):466\u201377.","journal-title":"Mov Disord"},{"issue":"11","key":"578_CR166","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2174\/0118715273377780250505115039","volume":"24","author":"S Kurmi","year":"2025","unstructured":"Kurmi S, Doshi G, Parab SB. The NLRP3-P2X7 axis and cytokine crosstalk in Alzheimer\u2019s disease: mechanisms, implications, and therapeutic opportunities. CNS Neurol Disord Drug Targets. 2025;24(11):795\u2013822.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"578_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2024.102776","volume":"85","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Cheng F. Artificial intelligence for drug discovery and development in Alzheimer\u2019s disease. Curr Opin Struct Biol. 2024;85:102776.","journal-title":"Curr Opin Struct Biol"},{"issue":"7","key":"578_CR168","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.tips.2024.05.005","volume":"45","author":"B Turgutalp","year":"2024","unstructured":"Turgutalp B, Kizil C. Multi-target drugs for Alzheimer\u2019s disease. Trends Pharmacol Sci. 2024;45(7):628\u201338.","journal-title":"Trends Pharmacol Sci"},{"key":"578_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102172","volume":"93","author":"C Geng","year":"2024","unstructured":"Geng C, Wang Z, Tang Y. Machine learning in Alzheimer\u2019s disease drug discovery and target identification. Ageing Res Rev. 2024;93:102172.","journal-title":"Ageing Res Rev"},{"key":"578_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102199","volume":"94","author":"N Liu","year":"2024","unstructured":"Liu N, Liang X, Chen Y, Xie L. Recent trends in treatment strategies for Alzheimer\u2019s disease and the challenges: a topical advancement. Ageing Res Rev. 2024;94:102199.","journal-title":"Ageing Res Rev"},{"issue":"3","key":"578_CR171","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1007\/s12035-024-04419-7","volume":"62","author":"S Le Bars","year":"2025","unstructured":"Le Bars S, Glaab E. Single-cell cortical transcriptomics reveals common and distinct changes in cell-cell communication in Alzheimer\u2019s and Parkinson\u2019s disease. Mol Neurobiol. 2025;62(3):2655\u201373.","journal-title":"Mol Neurobiol"},{"issue":"11","key":"578_CR172","doi-asserted-by":"publisher","first-page":"7859","DOI":"10.1002\/alz.14253","volume":"20","author":"RJ Perrin","year":"2024","unstructured":"Perrin RJ, Franklin EE, Bernhardt H, Burns A, Schwetye KE, Cairns NJ, et al. The Alzheimer\u2019s disease neuroimaging initiative neuropathology core: an update. Alzheimers Dement. 2024;20(11):7859\u201370.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"578_CR173","doi-asserted-by":"publisher","DOI":"10.3390\/biom14040398","volume":"14","author":"L Cheslow","year":"2024","unstructured":"Cheslow L, Snook AE, Waldman SA. Biomarkers for managing neurodegenerative diseases. Biomolecules. 2024;14(4):398.","journal-title":"Biomolecules"},{"issue":"5","key":"578_CR174","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/s41591-024-02923-w","volume":"30","author":"Q Xu","year":"2024","unstructured":"Xu Q, Liang Z, Huang Y. APOE4 homozygosity is a new genetic form of Alzheimer\u2019s disease. Nat Med. 2024;30(5):1241\u20132.","journal-title":"Nat Med"},{"key":"578_CR175","doi-asserted-by":"publisher","DOI":"10.1177\/13872877251407700","author":"TA Oso","year":"2025","unstructured":"Oso TA, Ahmed MM, Okesanya OJ, Adebayo UO, Obadeyi KB, Othman ZK, et al. Exploring the gut-brain-microbiome axis in Alzheimer\u2019s disease: integrating metagenomics, metabolomics, and artificial intelligence for next-generation biomarker discovery. J Alzheimers Dis. 2025. https:\/\/doi.org\/10.1177\/13872877251407700.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"578_CR176","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/17425247.2024.2331216","volume":"21","author":"D Unnithan","year":"2024","unstructured":"Unnithan D, Sartaj A, Iqubal MK, Ali J, Baboota S. A neoteric annotation on the advances in combination therapy for Parkinson\u2019s disease: nanocarrier-based combination approach and future anticipation. Part II: nanocarrier design and development in focus. Expert Opin Drug Deliv. 2024;21(3):437\u201356.","journal-title":"Expert Opin Drug Deliv"},{"key":"578_CR177","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jconrel.2019.12.034","volume":"319","author":"D Gopalan","year":"2020","unstructured":"Gopalan D, Pandey A, Udupa N, Mutalik S. Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: role of surface engineered nanocarriers. J Control Release. 2020;319:183\u2013200.","journal-title":"J Control Release"},{"issue":"2","key":"578_CR178","volume":"19","author":"X Wu","year":"2024","unstructured":"Wu X, Yuan R, Xu Y, et al. Functionalized lipid nanoparticles modulate the blood-brain barrier and eliminate \u03b1-synuclein to repair dopamine neurons. Asian J Pharm Sci. 2024;19(2):100904.","journal-title":"Asian J Pharm Sci"},{"key":"578_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.125069","volume":"669","author":"ZF Yang","year":"2025","unstructured":"Yang ZF, Jiang XC, Gao JQ. Present insights into the progress in gene therapy delivery systems for central nervous system diseases. Int J Pharm. 2025;669:125069.","journal-title":"Int J Pharm"},{"key":"578_CR180","doi-asserted-by":"publisher","first-page":"1332845","DOI":"10.3389\/fnagi.2024.1332845","volume":"16","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Ai W, Zheng J, Hu X, Zhang L. A bibliometric and visual analysis of epigenetic research publications for Alzheimer\u2019s disease (2013\u20132023). Front Aging Neurosci. 2024;16:1332845.","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"578_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.104052","volume":"29","author":"M Pereira","year":"2024","unstructured":"Pereira M, Cruz MT, Fortuna A, Bicker J. Restoring the epigenome in Alzheimer\u2019s disease: advancing HDAC inhibitors as therapeutic agents. Drug Discov Today. 2024;29(7):104052.","journal-title":"Drug Discov Today"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00578-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-026-00578-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00578-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T08:01:46Z","timestamp":1786953706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40035-026-00578-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":181,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["578"],"URL":"https:\/\/doi.org\/10.1186\/s40035-026-00578-w","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"38"}}